In vitro and in vivo evaluation of Triptolide-loaded Pluronic P105 polymeric micelles

Arzneimittel-Forschung/Drug Research

Volumn 62, Issue 7, 2012, Pages 340-344

  Li, H ^a   Wen, X S ^a   Di, W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

biodistribution study; in vitro release; pharmacokinetic study; TP loaded micelles

Indexed keywords

DRUG CARRIER; PLURONIC P105; POLOXAMER; TRIPTOLIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DYNAMIC LIGHT SCATTERING; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MALE; NONHUMAN; OVARY; PARTICLE SIZE; RAT; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DITERPENES; EPOXY COMPOUNDS; MALE; MICELLES; PHENANTHRENES; POLOXAMER; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 84864129377     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0032-1312602     Document Type: Article

References (25)

1. Barnes M N, Grizzle W E, Grubbs C J et al. Paradigms for primary prevention of ovarian carcinoma. CA Cancer J Clin: 2002; 52 216 225
2. Rouzier R, Extra J M, Carton M et al. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breastconserving surgery. J Clin Oncol: 2001; 19 3828 3835 (Pubitemid 32880061)
3. Yokoyama Y, Moriya T, Takano T et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br J Cancer: 2006; 94 1586 1591 (Pubitemid 43924918)
4. Su D, Song Y, Li R. Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii. Zhong Xi Yi Jie He Za Zhi: 1990; 10 144 146
5. Yang S X, Gao H L, Xie S S et al. Immunosuppression of triptolide and its effect on skin allograft survival. Int J Immunopharmacol: 1992; 14 963 969
6. Hachida HL M, Enosawa S, Suzuki XKL S et al. Immunosuppressive effect of triptolide in vitro. Transplant P: 1999; 3 2056 2057 (Pubitemid 29376525)
7. Zhang T M, Chen Z Y, Lin C. Antineoplastic action of triptolide and its effect on the immunologic functions in mice. Acta Pharmacol Sin: 1981; 2 128 131 (Pubitemid 11043814)
8. Zhang L X, Pan D J, Zhang W J et al. Inhibitory effect of tripterine on lymphocyte proliferation in mice. Acta Pharmacol Sin: 1986; 7 85 88
9. Qian S Z, Xu Y, Zhang J W. Recent progress in research on Tripterygium: a male antifertility plant. Contraception: 1995; 5 121 129
10. Hikim AP S, Lue Y H, Wang C et al. Post-testicular antifertility action of triptolide in the male rat: evidence for severe impairment of caude epididymal sperm ultrastructure. J Androl: 2000; 21 431 437 (Pubitemid 30252515)
11. He M F, Huang Y H, Wu L W et al. Triptolide functions as a potent angiogenesis inhibitor. Int J Cancer: 2010; 126 266 278
12. Zhu W, Ou Y, Li Y et al. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol: 2009; 75 812 819
13. Yang S, Chen J, Guo Z et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther: 2003; 2 65 72
14. Shi X, Jin Y, Cheng C et al. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Clin Cancer Res: 2009; 15 1686 1697
15. Tengchaisri T, Chawengkirttikul R, Rachaphaew N et al. Sirisinha. Anti-tumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Lett: 1998; 133 169 175 (Pubitemid 29069041)
16. Chan E W, Cheng S C, Sin F W et al. Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines. Toxicol Lett: 2001; 122 81 87
17. Kiviharju T M, Lecane P S, Sellers R G et al. Antiproliferative and proapoptotic activities of triptolide (PG490), A natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res: 2002; 8 2666 2674 (Pubitemid 34856355)
18. Yang S M, Chen J G, Guo Z et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther: 2003; 2 65 72
19. Zhou G X, Ding X L, Huang J F et al. Suppression of 5-lipoxygenase gene is involved in triptolide-induced apoptosis in pancreatic tumor cell lines. Biochem Biophys Acta: 2007; 1770 1021 1027 (Pubitemid 46678610)
20. Westfall S D, Nilsson E E, Skinner M K. Role of triptolide as an adjunct chemotherapy for ovarian cancer. Chemotherapy: 2008; 54 67 76 (Pubitemid 350308288)
21. Yu H Y, Qin W Z. Selectness of active compounds in Tripterygium wilfordii and study on its toxicity. J Zhejiang Coll TCM: 2000; 24 70 71
22. Xiong F L, Chen H B, Chang X L et al. Research progress of triptolide-loaded nanoparticles delivery systems. Conf Proc IEEE Eng Med Biol Soc: 2005; 5 4966 4969 (Pubitemid 46230063)
23. Zheng Q, Gong T, Sun X et al. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide. Arch Pharm Res: 2006; 29 1164 1170
24. Lin W J, Chen Y C, Lin C C et al. Characterization of pegylated copolymeric micelles and in vivo pharmacokinetics and biodistribution studies. J Biomed Mater Res B Appl Biomater: 2006; 77 188 194
25. Kabanov A V, Alakhov V Y. Pluronic (R) block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst: 2002; 19 1 72 (Pubitemid 34521248)